Eurofins Scientific Sa (ERFSF) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Eurofins Scientific Se.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.594 Ladies and gentlemen, welcome and thank you for joining Eurofins' nine-month 2025 trading. 00:00:05.756 -- 00:00:09.260 I believe that this call is being recorded and will later be available for replay on 00:00:09.260 -- 00:00:13.964 the Eurofins Investor Relations website. Throughout today's presentation, all participants 00:00:13.964 -- 00:00:18.068 will be in a listen-only mode. The presentation will be followed by a question and answer 00:00:18.068 -- 00:00:23.854 session. If you would like to ask a question, you may press star followed by 00:00:23.854 -- 00:00:26.036 zero to register for questions. 00:00:26.036 -- 00:00:30.760 For operator assistance, please press the star key followed by zero. 00:00:30.760 -- 00:00:34.584 During this call, Eurofins management may make forward-looking statements including, 00:00:34.584 -- 00:00:39.009 but not limited to, statements with respect to outlook and the related assumptions. 00:00:39.009 -- 00:00:42.332 Management will also discuss alternative performance measures such as organic growth 00:00:42.332 -- 00:00:46.196 and EBITDA, which are defined in the footnotes of our press releases. 00:00:46.196 -- 00:00:49.580 Actual results may differ materially from objectives discussed. 00:00:49.580 -- 00:00:53.844 Risks and uncertainties that may affect Eurofins' future results include, but are not 00:00:53.844 -- 00:00:58.249 limited to, those described in the risk factors section of the most recent Eurofins annual 00:00:58.249 -- 00:01:02.942 and half-year reports. Please also read the disclaimer on page two of this presentation, 00:01:02.942 -- 00:01:05.887 subject to which this call and Q&A session are made. 00:01:05.887 -- 00:01:07.730 I would now like to turn the conference over to Dr. 00:...